Photodynamic Therapy With LUZ11 in Advanced Head and Neck Cancer
NCT02070432
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Head and Neck Cancer
Interventions
DRUG:
LUZ11
Sponsor
Luzitin SA